Dexamethasone in Treatment of Comorbid SARS-CoV-2 Patients Aged over 50 Years with Lung Injury over 50 %

Dexamethasone in Treatment of Comorbid SARS-CoV-2 Patients Aged over 50 Years with Lung Injury over 50 %

Aim. An efficacy assessment of steroid therapy in SARS-CoV-2 patients aged over 50 years with lung damage over 50 % (grade 3–4).Materials and methods. A retrospective study of 158 SARS-CoV-2 patients hospitalised in April—June 2020 was conducted under the inclusion criteria: age over 50 years, chest...

Full description

Saved in:
Bibliographic Details
Main Authors: O. Yu. Zolnikova, R. V. Maslennikov, V. T. Ivashkin, N. L. Dzhakhaya, O. Yu. Kiseleva, N. D. Potskhverashvili, S. A. Shorokhova
Format: Article
Language:Russian
Published: Gastro LLC 2021-10-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
covid-19
dexamethasone
computed tomography
pneumonia conflict of interest: the authors declare no conflict of interest
Online Access:https://www.gastro-j.ru/jour/article/view/600
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.gastro-j.ru/jour/article/view/600

Similar Items